Sponsor Pipeline

Inge Marie Svane Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03563729 Melanoma Metastasized to the Brain and Steroids Malignant Melanoma Recruiting
Phase 1
NCT06783270 T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with… Melanoma Metastatic Recruiting
NCT06204991 To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or… Melanoma Stage III Recruiting
NCT07501117 Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma Uveal Melanoma Recruiting
NCT07694414 Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events Immune-Related Adverse Events Not Yet Recruiting
Disease Areas
Melanoma (4)
Get alerts when Inge Marie Svane's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free